Vivimed Labs Limited (NSE:VIVIMEDLAB)
India · Delayed Price · Currency is INR 5.07
-0.07 (-1.36%)
Jul 31, 2026, 3:29 PM IST
Vivimed Labs Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -1,765 | -319.61 | -454.46 | -3,285 | -676.5 |
Depreciation & Amortization | 260.52 | 202.24 | 199.41 | 191.27 | 182.82 |
Asset Writedown & Restructuring Costs | - | - | - | 892.8 | - |
Other Operating Activities | 52.19 | 33.49 | 165.5 | 337.89 | 431.35 |
Change in Accounts Receivable | 287.78 | 87.1 | -86.64 | 105.54 | 201.39 |
Change in Inventory | 460.4 | 53.07 | 156.98 | 1,610 | 149.17 |
Change in Accounts Payable | 113.04 | -46.44 | -111.62 | 275.19 | 76.42 |
Change in Income Taxes | - | -1.78 | - | - | - |
Change in Other Net Operating Assets | 667.82 | -25.58 | -109.08 | 225.83 | -89.25 |
Operating Cash Flow | 77.03 | -17.51 | -239.91 | 353.22 | 275.4 |
Operating Cash Flow Growth | - | - | - | 28.26% | -95.14% |
Capital Expenditures | -9.47 | -45.31 | -20.39 | -49.68 | -164.1 |
Investment in Securities | - | - | 303.26 | - | - |
Investing Cash Flow | -9.47 | -45.31 | 282.87 | -49.68 | -164.1 |
Short-Term Debt Issued | - | 80 | - | - | 224.56 |
Long-Term Debt Issued | - | - | - | 21.21 | 69.26 |
Total Debt Issued | - | 80 | - | 21.21 | 293.82 |
Short-Term Debt Repaid | -19.36 | - | - | - | - |
Long-Term Debt Repaid | - | -0.89 | -36 | - | - |
Total Debt Repaid | -19.36 | -0.89 | -36 | - | - |
Net Debt Issued (Repaid) | -19.36 | 79.11 | -36 | 21.21 | 293.82 |
Other Financing Activities | -41.71 | -29.47 | -24.33 | -359.03 | -397.61 |
Financing Cash Flow | -61.07 | 49.64 | -60.33 | -337.82 | -103.79 |
Miscellaneous Cash Flow Adjustments | -0.01 | - | - | 0.06 | 0.02 |
Net Cash Flow | 6.48 | -13.18 | -17.37 | -34.22 | 7.53 |
Free Cash Flow | 67.56 | -62.82 | -260.3 | 303.54 | 111.3 |
Free Cash Flow Growth | - | - | - | 172.72% | -98.04% |
Free Cash Flow Margin | 8.85% | -5.21% | -16.37% | 16.14% | 4.67% |
Free Cash Flow Per Share | 0.81 | -0.76 | -3.14 | 3.66 | 1.34 |
Levered Free Cash Flow | 1,019 | 97.2 | -254.94 | 607.08 | -134.38 |
Unlevered Free Cash Flow | 1,045 | 108.05 | -247.35 | 825.86 | 106.5 |
Cash Interest Paid | 41.7 | 29.47 | 24.32 | 359.03 | 397.6 |
Cash Income Tax Paid | 0.39 | -0.91 | 0.94 | - | - |
Change in Working Capital | 1,529 | 66.37 | -150.36 | 2,217 | 337.73 |